[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

The Top 50 Transdermal Drug Delivery Technology Companies Worldwide

December 2012 | 142 pages | ID: T9D57F8577BEN
Research Facts

US$ 464.00

E-mail Delivery (PDF), Hard Copy Mail Delivery

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
The Top 50 Transdermal Drug Delivery Technology Companies Worldwide completely updates and significantly expands, (from 98 to 142 pages), The Top 40 Transdermal Drug Delivery Technology Companies Worldwide, which was published in July, 2009. It takes account of all recent mergers, acquisitions and liquidations, documents e.g. changes to senior management (and their contact details) and describes additional products and new technologies. Most importantly, the report contains ten companies that were not included in the first report e.g. Janisys Limited - spun out from the Galway, Ireland medical device developer, Crospon Ltd., in January 2010, the Company’s drug delivery platform, which leverages ink-jet printing technology licensed from Hewlett-Packard, enables painless, controlled release of one or more drugs in a single patch to the skin.

The US Food and Drug Administration (FDA) approved the first transdermal patch products in 1981. These delivery systems provided the controlled systemic absorption of scopolamine for the prevention of motion sickness (Transderm-Scop) and nitroglycerine for the prevention of angina pectoris associated with coronary artery disease (Transderm-Nitro). Until the commercial success of these products, it was still perceived too difficult for an active molecule to overcome the barrier properties of human skin and penetrate into the blood system at adequate quantities to elicit a therapeutic effect.

In recent years, the transdermal route of drug delivery has evolved considerably and it now competes with oral treatment. A number of transdermal technologies have been developed which employ active delivery, in which the stratum corneum is breached to enhance the permeability of the skin. These active transdermal technologies include iontophoresis, electroporation, microneedles, abrasion, needleless injection, suction, stretching, ultrasound, magnetophoresis, radio frequency, lasers, photomechanical waves, and temperature manipulation. As a consequence of the development of these technologies many more new products comprised of therapeutic proteins and peptides for transdermal delivery will be seen.

It is estimated that the market value for transdermal delivery increased to $21.5 billion in 2010 and it is expected to increase to $31.5 billion in the year 2015.

There are many drug delivery technology companies worldwide. This report profiles the Top 50 transdermal ones. These are the companies with the most innovative and effective technologies and the largest intellectual property estates.

Profile information for each company in The Top 50 Transdermal Drug Delivery Technology Companies Worldwide typically includes:
  • Company Contact Information - Address, Telephone and Fax Numbers, Email and Website Address
  • Key Company Decision Makers - From CEO and Main Board, to Key Senior Managers
  • Specialised fields such as Company Description, Ownership, Products, Technology, Therapeutic Areas, IP Status, Year Established, Number of Employees and Turnover.
Report Target Market:

1) Drug Delivery Technology Companies

Usage: competitive/financial analysis and strategic partner/alliance identification.

2) Pharmaceutical, Biotechnology & Cosmeceutical Companies

This report is perfect for pharmaceutical, biotechnology and cosmeceutical companies who wish to identify leading, novel and proprietary transdermal drug delivery technologies.

3) Suppliers

The Top 50 Transdermal Drug Delivery Technology Companies Worldwide is useful to suppliers of components such as backing films, release liners and pressure-sensitive adhesives, to identify new potential customers.

Note: Most people will be aware of some of the major transdermal drug delivery technology companies such as Noven Pharmaceuticals, Inc. and TransPharma Medical Ltd. but this report looks at all 50 of the top companies – companies like – Pantec Biosolutions AG – a Liechtenstein based developer of the P.L.E.A.S.E. platform, a novel, injection free method for intraepidermal delivery of large molecular weight drugs.

Report data field structure is as follows:
  • Company Name
  • Mailing Address
  • Street Address
  • Telephone
  • Fax
  • Email
  • Website
  • Parent Company Name
  • Year Established
  • Number of Employees
  • Key Executives
  • Company Description
  • Products
  • Technology
  • Therapeutic Areas
  • IP Status
  • Turnover €m
  • Location Status
  • Ownership
Research Facts is a world leader in life sciences publishing. It was established in Dublin, Ireland in 2004. Its partners have over forty years combined experience in the business information industry. Research Facts’ customers include most of the world’s major diagnostics, pharmaceutical, biotechnology and medical device companies e.g. Abbott, Allergan, B. Braun, Bayer, Baxter, Biomet, Boehringer Ingelheim, Covance, Edwards Lifesciences, GE Healthcare, Genzyme, Intuitive Surgical, Ipsen, Medtronic, Millipore, Philips Medical, Qiagen, Siemens Healthcare, Smith & Nephew, Zentiva etc.

Research Facts has customers right across the globe e.g. Austria, Australia, Belgium, Brazil, Canada, Cyprus, Czech Republic, Denmark, France, Germany, Finland, Hungary, Ireland, Israel, Italy, Japan, Korea, Kuwait, Luxembourg, Mauritius, Netherlands, Pakistan, Portugal, Russia, Saudi Arabia, Slovenia, South Africa, Spain, Sweden, Switzerland, United Kingdom, and the United States.

Research Facts’ reports help you make informed decisions about the markets and organisations that affect your business.
  • Learn more about your target markets and target companies
  • Top level research on all the major players in a market
  • See which organisations dominate your major markets
  • Get detailed information on particular organisations

The scientific advisor on this report was Katie Ryan. Katie has degrees in physiology and medicine from Trinity College Dublin and is a full-time researcher there in the School of Medicine.


Transdermal Drug Delivery, TDDS, Active Delivery, Iontophoresis, Electrophoresis, Microneedle, NeedleLess Injection, Ultrasound, Magnetophoresis, Radio Frequency, Lasers.

More Publications